Hennigsdorf, Germany Clinical Trials

A listing of Hennigsdorf, Germany clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]

This is a prospective, multicenter, double-blind, placebo-controlled, randomized Phase 3 study. The purpose of the study is to obtain evidence of efficacy for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recurrent disease who are in partial or complete response after having …

maintenance therapy
renal function
liver metastasis
adjuvant chemotherapy
recurrent endometrial cancer
Charite Berlin Universitatsmedizin
 (8.8 away) Contact site
  • 47 views
  • 04 Jun, 2021
  • +102 other locations
Prevention of the Age-Related Cognitive Impairment by Exercise and Mental Activity - Berlin Bleibt Fit

The trial will evaluate the effects of frequent exercise and increased mental activity on the age-related impairment of cognitive function in elderly women. Furthermore, we will assess the effects of exercise and mental activity on the mood, physical performance and mental status of participants. We will also search for genetic …

Department of Psychiatry
 (8.3 away) Contact site
  • 10 views
  • 07 Nov, 2020
  • 1 location
A Study With Pembrolizumab in Combination With Dual Anti-HER2 Blockade With Trastuzumab and Pertuzumab in Early Breast Cancer Patients With Molecular HER2-enriched Intrinsic Subtype (Keyriched-1)

Keyriched-1 is a multicenter, interventional, prospective, single arm, open label, neoadjuvant phase II trial evaluating the pathological complete response (pCR) rate induced by pembrolizumab in combination with the dual anti-HER2 blockade consisting of trastuzumab biosimilar ABP 980 and pertuzumab in early breast cancer patients with molecular HER2-enriched intrinsic subtype tested …

pertuzumab
HER2
magnetic resonance imaging of breast
progesterone
erbb2
Ev. Waldkrankenhaus Spandau
 (4.9 away) Contact site
  • 89 views
  • 26 Jan, 2021
  • +14 other locations
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial Fallopian Tube or Peritoneal Cancer

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Hyperthermia therapy kills tumor cells by heating them to several degrees above body temperature. Combining hyperthermia with chemotherapy may kill more tumor cells. It is not yet known if chemotherapy …

tumor cells
carboplatin
cancer
peritoneal cancer
gynecologic cancer
Charite University Hospital - Campus Virchow Klinikum
 (8.8 away) Contact site
  • 61 views
  • 07 Nov, 2020
  • +3 other locations
Management of Retained Placenta With the "Windmill" Technique of Umbilical Cord Traction

The incidence of leftover placenta after vaginal delivery is between 0.1% and 3.3%, with a maternal mortality of up to 10% reported. The traditional management is ultimately the manual removal of the retained placenta (MROP) in the operating room. However, MROP itself increases the risk of further bleeding, postpartum infection, …

Charit University Hospital
 (8.8 away) Contact site
  • 0 views
  • 23 Jan, 2021
  • 1 location
Comparison of QoL Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

This is a multicenter, randomized, controlled, open-label study including patients with recurrent, platinum-sensitive, ovarian, peritoneal or fallopian tube cancer. The main scope of the trial is to evaluate QoL during chemotherapy comparing trabectedin/PLD with other standard platinum-based chemotherapy in platinum-sensitive disease.

gemcitabine
carboplatin
cancer of the ovary
paclitaxel
peritoneal carcinoma
Praxis Krebsheilkunde f r Frauen
 (7.1 away) Contact site
  • 9 views
  • 26 Jan, 2021
  • +33 other locations
Efficacy of Herbal Galactagogue Silitidil After Preterm Birth

After preterm birth mothers often suffer from hypogalactia. Herbal galactogogues can be used in order to increase milk production. In this double-blind, randomized, placebo-controlled clinical trial the effect of Silitidil, an extract from milk thistle, on the postpartal milk production in mothers of very premature newborns is investigated.

Evangelic Waldkrankenhaus Spandau, Paul Gerhardt Diakonie
 (4.9 away) Contact site
  • 9 views
  • 09 May, 2021
  • 1 location